Synthesis and in vivo proof of concept of a BODIPY-based fluorescent probe as a tracer for biodistribution studies of a new anti-Chagas agent

Rodríguez, Gonzalo - Nargoli, Javier - López, Andrés - Moyna, Guillermo - Álvarez, Guzmán - Fernández, Marcelo - Osorio-Martínez, Carlos A - González, Mercedes - Cerecetto, Hugo

Resumen:

The potential use of amide-containing thiazoles, especially (2E,2Z)-3-allyl-4-[((E)-4-cinnamylpiperazin-1-yl)carbonyl]-2-[2-((E)-3-(furan-2-yl)propenylidene)hydrazono]-2,3-dihydrothiazole (1), as drugs for the treatment of Chagas disease has been recently described. The therapeutic application of 1 requires further pre-clinical studies, including in vivo biodistribution. In this sense, a BODIPY-fluorophore based probe for this drug (1-BODIPY) was developed and investigated for its potential as an in vivo tracer. The fluorescent tracer was synthesized, physicochemically and in vitro biologically characterised, and its in vivo biodistribution evaluated. The in vitro studies demonstrated that the fluorescent probe could simulate the in vivo behaviour of compound 1. Furthermore, the in vivo proof of concept showed that the 1-BODIPY biodistribution involves organs that are associated with the parasitic disease. These findings allow us to establish future administration routes and regimens in the treatment of Chagas disease with 1.


Detalles Bibliográficos
2017
Fluorescence
Probes
Biodistributions
Chagas disease
Fluorescent probes
Fluorescent tracers
Therapeutic application
Inglés
Universidad de la República
COLIBRI
https://hdl.handle.net/20.500.12008/22015
Acceso abierto
Licencia Creative Commons Atribución (CC –BY 4.0)
_version_ 1807522779532099584
author Rodríguez, Gonzalo
author2 Nargoli, Javier
López, Andrés
Moyna, Guillermo
Álvarez, Guzmán
Fernández, Marcelo
Osorio-Martínez, Carlos A
González, Mercedes
Cerecetto, Hugo
author2_role author
author
author
author
author
author
author
author
author_facet Rodríguez, Gonzalo
Nargoli, Javier
López, Andrés
Moyna, Guillermo
Álvarez, Guzmán
Fernández, Marcelo
Osorio-Martínez, Carlos A
González, Mercedes
Cerecetto, Hugo
author_role author
bitstream.checksum.fl_str_mv 7f2e2c17ef6585de66da58d1bfa8b5e1
4fe6ac477f5a2df0424a5ff1a9bf000c
a0ebbeafb9d2ec7cbb19d7137ebc392c
bc1bc9659a4a06e9516479a5adfd8b0e
9bf346c02b7b72739455e98183b58e9c
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
bitstream.url.fl_str_mv http://localhost:8080/xmlui/bitstream/20.500.12008/22015/5/license.txt
http://localhost:8080/xmlui/bitstream/20.500.12008/22015/2/license_text
http://localhost:8080/xmlui/bitstream/20.500.12008/22015/3/license_url
http://localhost:8080/xmlui/bitstream/20.500.12008/22015/4/license_rdf
http://localhost:8080/xmlui/bitstream/20.500.12008/22015/1/101039c6ra27851e.pdf
collection COLIBRI
dc.contributor.filiacion.es.fl_str_mv Rodríguez, Gonzalo. Universidad de la República (Uruguay). Facultad de Ciencias. Instituto de Química Biológica
Nargoli, Javier. Universidad de la República (Uruguay). Facultad de Ciencias. Instituto de Química Biológica
López, Andrés. Universidad de la República (Uruguay). CENUR
Moyna, Guillermo. Universidad de la República (Uruguay)
Álvarez, Gúzman. Facultad de Ciencias. Instituto de Química Biológica
Fernández, Marcelo. Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares
Osorio-Martínez, Carlos A. Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares
González, Mercedes. Universidad de la República (Uruguay). Facultad de Ciencias. Instituto de Química Biológica
Cerecetto Meyer, Hugo. Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares.
dc.creator.none.fl_str_mv Rodríguez, Gonzalo
Nargoli, Javier
López, Andrés
Moyna, Guillermo
Álvarez, Guzmán
Fernández, Marcelo
Osorio-Martínez, Carlos A
González, Mercedes
Cerecetto, Hugo
dc.date.accessioned.none.fl_str_mv 2019-10-02T22:08:27Z
dc.date.available.none.fl_str_mv 2019-10-02T22:08:27Z
dc.date.issued.es.fl_str_mv 2017
dc.date.submitted.es.fl_str_mv 20190930
dc.description.abstract.none.fl_txt_mv The potential use of amide-containing thiazoles, especially (2E,2Z)-3-allyl-4-[((E)-4-cinnamylpiperazin-1-yl)carbonyl]-2-[2-((E)-3-(furan-2-yl)propenylidene)hydrazono]-2,3-dihydrothiazole (1), as drugs for the treatment of Chagas disease has been recently described. The therapeutic application of 1 requires further pre-clinical studies, including in vivo biodistribution. In this sense, a BODIPY-fluorophore based probe for this drug (1-BODIPY) was developed and investigated for its potential as an in vivo tracer. The fluorescent tracer was synthesized, physicochemically and in vitro biologically characterised, and its in vivo biodistribution evaluated. The in vitro studies demonstrated that the fluorescent probe could simulate the in vivo behaviour of compound 1. Furthermore, the in vivo proof of concept showed that the 1-BODIPY biodistribution involves organs that are associated with the parasitic disease. These findings allow us to establish future administration routes and regimens in the treatment of Chagas disease with 1.
dc.format.mimetype.es.fl_str_mv application/pdf
dc.identifier.citation.es.fl_str_mv Rodríguez, G., et al. Synthesis and in vivo proof of concept of a BODIPY-based fluorescent probe as a tracer for biodistribution studies of a new anti-Chagas agent. RSC Advances, 2017, 7 (13), 7983-7989. doi:10.1039/c6ra27851e
dc.identifier.doi.es.fl_str_mv 10.1039/c6ra27851e
dc.identifier.issn.es.fl_str_mv 2046-2069
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12008/22015
dc.language.iso.none.fl_str_mv en
eng
dc.publisher.es.fl_str_mv Royal Society of Chemistry
dc.relation.ispartof.es.fl_str_mv RSC Advances, 2017, 7 (13), 7983-7989
dc.rights.license.none.fl_str_mv Licencia Creative Commons Atribución (CC –BY 4.0)
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.source.none.fl_str_mv reponame:COLIBRI
instname:Universidad de la República
instacron:Universidad de la República
dc.subject.es.fl_str_mv Fluorescence
Probes
Biodistributions
Chagas disease
Fluorescent probes
Fluorescent tracers
Therapeutic application
dc.title.none.fl_str_mv Synthesis and in vivo proof of concept of a BODIPY-based fluorescent probe as a tracer for biodistribution studies of a new anti-Chagas agent
dc.type.es.fl_str_mv Artículo
dc.type.none.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
description The potential use of amide-containing thiazoles, especially (2E,2Z)-3-allyl-4-[((E)-4-cinnamylpiperazin-1-yl)carbonyl]-2-[2-((E)-3-(furan-2-yl)propenylidene)hydrazono]-2,3-dihydrothiazole (1), as drugs for the treatment of Chagas disease has been recently described. The therapeutic application of 1 requires further pre-clinical studies, including in vivo biodistribution. In this sense, a BODIPY-fluorophore based probe for this drug (1-BODIPY) was developed and investigated for its potential as an in vivo tracer. The fluorescent tracer was synthesized, physicochemically and in vitro biologically characterised, and its in vivo biodistribution evaluated. The in vitro studies demonstrated that the fluorescent probe could simulate the in vivo behaviour of compound 1. Furthermore, the in vivo proof of concept showed that the 1-BODIPY biodistribution involves organs that are associated with the parasitic disease. These findings allow us to establish future administration routes and regimens in the treatment of Chagas disease with 1.
eu_rights_str_mv openAccess
format article
id COLIBRI_60a23925a0f6a802f7c1b9e2e5071052
identifier_str_mv Rodríguez, G., et al. Synthesis and in vivo proof of concept of a BODIPY-based fluorescent probe as a tracer for biodistribution studies of a new anti-Chagas agent. RSC Advances, 2017, 7 (13), 7983-7989. doi:10.1039/c6ra27851e
2046-2069
10.1039/c6ra27851e
instacron_str Universidad de la República
institution Universidad de la República
instname_str Universidad de la República
language eng
language_invalid_str_mv en
network_acronym_str COLIBRI
network_name_str COLIBRI
oai_identifier_str oai:colibri.udelar.edu.uy:20.500.12008/22015
publishDate 2017
reponame_str COLIBRI
repository.mail.fl_str_mv mabel.seroubian@seciu.edu.uy
repository.name.fl_str_mv COLIBRI - Universidad de la República
repository_id_str 4771
rights_invalid_str_mv Licencia Creative Commons Atribución (CC –BY 4.0)
spelling Rodríguez, Gonzalo. Universidad de la República (Uruguay). Facultad de Ciencias. Instituto de Química BiológicaNargoli, Javier. Universidad de la República (Uruguay). Facultad de Ciencias. Instituto de Química BiológicaLópez, Andrés. Universidad de la República (Uruguay). CENURMoyna, Guillermo. Universidad de la República (Uruguay)Álvarez, Gúzman. Facultad de Ciencias. Instituto de Química BiológicaFernández, Marcelo. Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones NuclearesOsorio-Martínez, Carlos A. Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones NuclearesGonzález, Mercedes. Universidad de la República (Uruguay). Facultad de Ciencias. Instituto de Química BiológicaCerecetto Meyer, Hugo. Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares.2019-10-02T22:08:27Z2019-10-02T22:08:27Z201720190930Rodríguez, G., et al. Synthesis and in vivo proof of concept of a BODIPY-based fluorescent probe as a tracer for biodistribution studies of a new anti-Chagas agent. RSC Advances, 2017, 7 (13), 7983-7989. doi:10.1039/c6ra27851e2046-2069https://hdl.handle.net/20.500.12008/2201510.1039/c6ra27851eThe potential use of amide-containing thiazoles, especially (2E,2Z)-3-allyl-4-[((E)-4-cinnamylpiperazin-1-yl)carbonyl]-2-[2-((E)-3-(furan-2-yl)propenylidene)hydrazono]-2,3-dihydrothiazole (1), as drugs for the treatment of Chagas disease has been recently described. The therapeutic application of 1 requires further pre-clinical studies, including in vivo biodistribution. In this sense, a BODIPY-fluorophore based probe for this drug (1-BODIPY) was developed and investigated for its potential as an in vivo tracer. The fluorescent tracer was synthesized, physicochemically and in vitro biologically characterised, and its in vivo biodistribution evaluated. The in vitro studies demonstrated that the fluorescent probe could simulate the in vivo behaviour of compound 1. Furthermore, the in vivo proof of concept showed that the 1-BODIPY biodistribution involves organs that are associated with the parasitic disease. These findings allow us to establish future administration routes and regimens in the treatment of Chagas disease with 1.Made available in DSpace on 2019-10-02T22:08:27Z (GMT). No. of bitstreams: 5 101039c6ra27851e.pdf: 3055213 bytes, checksum: 9bf346c02b7b72739455e98183b58e9c (MD5) license_text: 38297 bytes, checksum: 4fe6ac477f5a2df0424a5ff1a9bf000c (MD5) license_url: 44 bytes, checksum: a0ebbeafb9d2ec7cbb19d7137ebc392c (MD5) license_rdf: 8067 bytes, checksum: bc1bc9659a4a06e9516479a5adfd8b0e (MD5) license.txt: 4194 bytes, checksum: 7f2e2c17ef6585de66da58d1bfa8b5e1 (MD5) Previous issue date: 2017application/pdfenengRoyal Society of ChemistryRSC Advances, 2017, 7 (13), 7983-7989Las obras depositadas en el Repositorio se rigen por la Ordenanza de los Derechos de la Propiedad Intelectual de la Universidad De La República. (Res. Nº 91 de C.D.C. de 8/III/1994 – D.O. 7/IV/1994) y por la Ordenanza del Repositorio Abierto de la Universidad de la República (Res. Nº 16 de C.D.C. de 07/10/2014)info:eu-repo/semantics/openAccessLicencia Creative Commons Atribución (CC –BY 4.0)FluorescenceProbesBiodistributionsChagas diseaseFluorescent probesFluorescent tracersTherapeutic applicationSynthesis and in vivo proof of concept of a BODIPY-based fluorescent probe as a tracer for biodistribution studies of a new anti-Chagas agentArtículoinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:COLIBRIinstname:Universidad de la Repúblicainstacron:Universidad de la RepúblicaRodríguez, GonzaloNargoli, JavierLópez, AndrésMoyna, GuillermoÁlvarez, GuzmánFernández, MarceloOsorio-Martínez, Carlos AGonzález, MercedesCerecetto, HugoLICENSElicense.txttext/plain4194http://localhost:8080/xmlui/bitstream/20.500.12008/22015/5/license.txt7f2e2c17ef6585de66da58d1bfa8b5e1MD55CC-LICENSElicense_textapplication/octet-stream38297http://localhost:8080/xmlui/bitstream/20.500.12008/22015/2/license_text4fe6ac477f5a2df0424a5ff1a9bf000cMD52license_urlapplication/octet-stream44http://localhost:8080/xmlui/bitstream/20.500.12008/22015/3/license_urla0ebbeafb9d2ec7cbb19d7137ebc392cMD53license_rdfapplication/octet-stream8067http://localhost:8080/xmlui/bitstream/20.500.12008/22015/4/license_rdfbc1bc9659a4a06e9516479a5adfd8b0eMD54ORIGINAL101039c6ra27851e.pdfapplication/pdf3055213http://localhost:8080/xmlui/bitstream/20.500.12008/22015/1/101039c6ra27851e.pdf9bf346c02b7b72739455e98183b58e9cMD5120.500.12008/220152021-05-20 21:10:44.421oai:colibri.udelar.edu.uy:20.500.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://udelar.edu.uy/https://www.colibri.udelar.edu.uy/oai/requestmabel.seroubian@seciu.edu.uyUruguayopendoar:47712024-07-25T14:28:06.891796COLIBRI - Universidad de la Repúblicafalse
spellingShingle Synthesis and in vivo proof of concept of a BODIPY-based fluorescent probe as a tracer for biodistribution studies of a new anti-Chagas agent
Rodríguez, Gonzalo
Fluorescence
Probes
Biodistributions
Chagas disease
Fluorescent probes
Fluorescent tracers
Therapeutic application
status_str publishedVersion
title Synthesis and in vivo proof of concept of a BODIPY-based fluorescent probe as a tracer for biodistribution studies of a new anti-Chagas agent
title_full Synthesis and in vivo proof of concept of a BODIPY-based fluorescent probe as a tracer for biodistribution studies of a new anti-Chagas agent
title_fullStr Synthesis and in vivo proof of concept of a BODIPY-based fluorescent probe as a tracer for biodistribution studies of a new anti-Chagas agent
title_full_unstemmed Synthesis and in vivo proof of concept of a BODIPY-based fluorescent probe as a tracer for biodistribution studies of a new anti-Chagas agent
title_short Synthesis and in vivo proof of concept of a BODIPY-based fluorescent probe as a tracer for biodistribution studies of a new anti-Chagas agent
title_sort Synthesis and in vivo proof of concept of a BODIPY-based fluorescent probe as a tracer for biodistribution studies of a new anti-Chagas agent
topic Fluorescence
Probes
Biodistributions
Chagas disease
Fluorescent probes
Fluorescent tracers
Therapeutic application
url https://hdl.handle.net/20.500.12008/22015